✦ LIBER ✦

Is there a role for imatinib in inflammatory bowel disease?

✍ Scribed by Ole De Backer; Romain A. Lefebvre

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 91 KB
Volume: 14
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20320

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is there any place for alimentary probio

Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?

✍ Philippe Seksik; Xavier Dray; Harry Sokol; Philippe Marteau 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract The pathogenesis of inflammatory bowel disease (IBD) involves an interaction between genetically determined host susceptibility, dysregulated immune response, and the enteric microbiota. Ecological treatments including probiotics, prebiotics, and synbiotics are actively studied in Crohn

Is metabolic stress a common denominator

Is metabolic stress a common denominator in inflammatory bowel disease?

✍ Ida Schoultz; Johan D. Söderholm; Derek M. McKay 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB 👁 1 views

The enteric epithelium represents the major boundary between the outside world and the body, and in the colon it is the interface between the host and a vast and diverse microbiota. A common feature of inflammatory bowel disease (IBD) is decreased epithelial barrier function, and while a cause-and-e

Role of diet in the development of infla

Role of diet in the development of inflammatory bowel disease

✍ Christine A. Chapman-Kiddell; Peter S.W. Davies; Lynda Gillen; Graham L. Radford 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

The inflammatory bowel diseases (IBDs) are a group of heterogeneous disorders characterized by acute and chronic inflammatory changes in the small or large bowel, or in both. Increasing incidence and prevalence figures for IBD both in the developed and developing world indicate that environmental fa

CCR6 has a non-redundant role in the dev

CCR6 has a non-redundant role in the development of inflammatory bowel disease

✍ Rosa Varona; Vanesa Cadenas; Juana Flores; Carlos Martínez-A.; Gabriel Márquez 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 2 views

Apolipoprotein A-IV is an independent pr

Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease

✍ Uli C. Broedl; Veronika Schachinger; Arno Lingenhel; Michael Lehrke; Renee Stark 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Background: Apoa-iv, an apolipoprotein (apo) with antioxidant, antiatherogenic, and antiinflammatory properties, was recently demonstrated to inhibit dextran sulfate sodium (dss)-induced experimental colitis in mice. we therefore hypothesized that apoa-iv may be associated with disease activity

The role of self-efficacy in inflammator

The role of self-efficacy in inflammatory bowel disease management: Preliminary validation of a disease-specific measure

✍ Laurie Keefer; Jennifer L. Kiebles; Tiffany H. Taft 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Background: Inflammatory bowel diseases (IBDs) require selfmanagement skills that may be influenced by self-efficacy (SE). Self-efficacy represents an individual's perception of his or her ability to organize and execute the behaviors necessary to manage disease. The goal of this study was to develo